v3.25.4
Share-Based Compensation Plans (Tables)
12 Months Ended
Dec. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Share-Based Compensation Expense Tax Benefit
Total share-based compensation expense recognized in income and the associated income tax benefit for the years ended December 31 were:
 
 Millions of Dollars
 202520242023
Restricted stock units$115 121 130 
Performance share units100 83 139 
Stock options2 4 19 
Other3 2 9 
Total share-based compensation expense$220 210 297 
Income tax benefit$(65)(84)(87)
Schedule of Stock Unit Activity
The following table summarizes our RSU activity from January 1, 2025, to December 31, 2025:

Stock UnitsWeighted-Average
Grant-Date
Fair Value
Outstanding at January 1, 20252,861,407 $109.20 
Granted995,345 128.09 
Forfeited(82,589)126.84 
Issued(1,508,654)97.98 
Outstanding at December 31, 20252,265,509 $124.34 
Not Vested at December 31, 20251,619,525 $124.22 
Schedule of Performance Share Program Activity
The following table summarizes our PSU activity from January 1, 2025, to December 31, 2025:
 

Performance
Share Units
Weighted-Average
Grant-Date 
Fair Value
Outstanding at January 1, 2025432,093 $37.75 
Granted883,094 119.96 
Forfeited— — 
Issued(102,290)36.74 
Cash settled(883,094)119.96 
Outstanding at December 31, 2025329,803 $38.06 
Schedule of Stock Option Activity
The following table summarizes our stock option activity from January 1, 2025, to December 31, 2025:


OptionsWeighted-Average
Exercise Price
Outstanding at January 1, 20254,056,466 $89.32 
Granted— — 
Forfeited(3,301)97.80 
Exercised(1,221,431)87.40 
Outstanding at December 31, 20252,831,734 $90.11 
Vested at December 31, 20252,769,822 $89.89 
Exercisable at December 31, 20252,582,241 $89.12 
Schedule of Fair Value Assumptions
The following table provides the significant assumptions used to calculate the grant-date fair values of options granted in 2023, as calculated using the Black-Scholes-Merton option-pricing model:
 
2023
Risk-free interest rate3.84 
Dividend yield3.80 
Volatility factor35.19 
Expected life (years)6.78
No options were granted in 2025 or 2024.